| | Baseline variables | Survivor () | Nonsurvivor () | value |
| | Age (IQR, years) | 57.75 (46.33-70.63) | 74.79 (61.52-82.23) | 0.035 | | Male (, %) | 165 (55.18%) | 24 (63.15%) | 0.195 | | Systolic blood pressure (IQR, mm Hg) | 133 (117.5-149.5) | 122.5 (109.5-154.5) | 0.322 | | Diastolic blood pressure (IQR, mm Hg) | 76 (64.5-87) | 67 (51.25-95.5) | 0.236 | | Heart rate (IQR, beats/min) | 101 (85-118) | 97 (87.25-117.75) | 0.726 | | WBC (IQR, ×109/L) | 13.1 (9.1-17.6) | 16.55 (12.63-22.4) | <0.001 | | PLT (IQR, ×109/L) | 228 (176-308) | 234 (195.75-331.25) | 0.532 | | MCV (IQR, fL) | 90 (87-95) | 89 (85-94.75) | 0.123 | | HCT (IQR) | 0.378 (0.327-0.42) | 0.351 (0.313-0.401) | 0.048 | | Glucose (IQR, mg/dL) | 137 (105.25-184.75) | 156 (120-235) | 0.656 | | PT (IQR, s) | 13.6 (12.8-14.9) | 14.7 (13.63-16) | <0.001 | | TT (IQR, s) | 27.7 (24.6-31.3) | 30.7 (27.15-33.58) | 0.12 | | Albumin (IQR, g/dL) | 3.2 (2.7-3.9) | 2.9 (2.25-3.35) | 0.052 | | Creatine kinase, MB isoenzyme (IQR, IU/L) | 4 (2-5) | 5 (2-8.25) | 0.025 | | ALT (IQR, IU/L) | 44 (22-128.5) | 49 (23.25-185) | 0.037 | | AST (IQR, IU/L) | 57 (30-131) | 74.5 (37.75-228.75) | 0.301 | | Total bilirubin (IQR, mg/dL) | 0.9 (0.5-1.8) | 1.45 (0.63-3.9) | <0.001 | | Creatinine (IQR, mg/dL) | 1 (0.7-1.4) | 1.55 (0.93-2.8) | 0.003 | | Amylase (IQR, IU/L) | 285 (92-786) | 324 (92.25-1088.5) | 0.046 | | Lipase (IQR, IU/L) | 557 (99-1754) | 656 (88.25-1248.25) | 0.033 | | LDH (IQR, IU/L) | 350 (240-517) | 395 (257-597.5) | 0.41 | | Total calcium (IQR, mg/dL) | 8.3 (7.7-8.9) | 7.85 (7.18-8.5) | 0.041 | | Sodium (IQR, mmol/L) | 139 (136-141) | 139 (137-142) | 0.444 | | Anion gap (IQR, mmol/L) | 15 (13-18.75) | 17 (14-20) | 0.482 | | Lactate (IQR, mmol/L) | 1.5 (1.2-2.4) | 1.8 (1.23-2.88) | 0.035 | | Triglyceride (IQR, mg/dL) | 139.5 (94-225) | 125 (70.5-227.25) | 0.364 | | Length of stay in ICU (IQR, days) | 3 (1.65-8.15) | 12.16 (4.44-18.04) | 0.002 | | SOFA (IQR) | 1 (0-2.5) | 2.5 (1.25-4) | <0.001 | | Ranson (IQR) | 1 (1-2) | 2 (2-3) | <0.001 |
|
|
